Direct-to-consumer genetic testing company 23andMe is merging with VG Acquisition Corp. with the aim of becoming publicly traded, as GenomeWeb reports. It notes VG Acquisition Corp. is a special-purpose acquisition company (SPAC) sponsored by Virgin Group.